Business Description
TSH Biopharm Corp Ltd
NAICS : 325412
SIC : 2834
ISIN : TW0008432006
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 30.17 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.19 | |||||
Interest Coverage | 126.05 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 7.39 | |||||
Beneish M-Score | -1.6 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.9 | |||||
3-Year EBITDA Growth Rate | 4.6 | |||||
3-Year EPS without NRI Growth Rate | -0.6 | |||||
3-Year FCF Growth Rate | 45.4 | |||||
3-Year Book Growth Rate | -0.6 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.49 | |||||
9-Day RSI | 35.41 | |||||
14-Day RSI | 38.49 | |||||
6-1 Month Momentum % | -0.53 | |||||
12-1 Month Momentum % | 24.45 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.39 | |||||
Quick Ratio | 4.6 | |||||
Cash Ratio | 3.65 | |||||
Days Inventory | 83.77 | |||||
Days Sales Outstanding | 51.07 | |||||
Days Payable | 25.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.31 | |||||
Dividend Payout Ratio | 0.57 | |||||
3-Year Dividend Growth Rate | -3.9 | |||||
Forward Dividend Yield % | 2.31 | |||||
5-Year Yield-on-Cost % | 1.85 | |||||
Shareholder Yield % | 2.65 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.5 | |||||
Operating Margin % | 9.67 | |||||
Net Margin % | 8.77 | |||||
FCF Margin % | 7.44 | |||||
ROE % | 7.53 | |||||
ROA % | 6.24 | |||||
ROIC % | 15.74 | |||||
3-Year ROIIC % | -6.8 | |||||
ROC (Joel Greenblatt) % | 63.19 | |||||
ROCE % | 8.74 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.33 | |||||
PE Ratio without NRI | 24.63 | |||||
Shiller PE Ratio | 24.58 | |||||
Price-to-Owner-Earnings | 45.64 | |||||
PEG Ratio | 7.24 | |||||
PS Ratio | 2.12 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 2.11 | |||||
Price-to-Free-Cash-Flow | 28.69 | |||||
Price-to-Operating-Cash-Flow | 27.71 | |||||
EV-to-EBIT | 12.11 | |||||
EV-to-EBITDA | 9.71 | |||||
EV-to-Revenue | 1.33 | |||||
EV-to-FCF | 18.82 | |||||
Price-to-Projected-FCF | 1.2 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Price-to-Graham-Number | 1.52 | |||||
Price-to-Net-Current-Asset-Value | 2.77 | |||||
Price-to-Net-Cash | 5.59 | |||||
Earnings Yield (Greenblatt) % | 8.26 | |||||
FCF Yield % | 3.49 | |||||
Forward Rate of Return (Yacktman) % | 4.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TSH Biopharm Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 1,002.833 | ||
EPS (TTM) (NT$) | 2.28 | ||
Beta | 0.48 | ||
Volatility % | 35.5 | ||
14-Day RSI | 38.49 | ||
14-Day ATR (NT$) | 1.550842 | ||
20-Day SMA (NT$) | 57.59 | ||
12-1 Month Momentum % | 24.45 | ||
52-Week Range (NT$) | 45.05 - 71.1 | ||
Shares Outstanding (Mil) | 38.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TSH Biopharm Corp Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TSH Biopharm Corp Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
TSH Biopharm Corp Ltd Frequently Asked Questions
What is TSH Biopharm Corp Ltd(ROCO:8432)'s stock price today?
When is next earnings date of TSH Biopharm Corp Ltd(ROCO:8432)?
Does TSH Biopharm Corp Ltd(ROCO:8432) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |